$
1.870
-0.24(-11.374%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

IMAB Relative Valuation

IMAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IMAB is overvalued; if below, it's undervalued.

Historical Valuation

I-Mab (IMAB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -18.34. The fair price of I-Mab (IMAB) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:1.94
Fair
-10.05
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
I-Mab. (IMAB) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 3.70. The thresholds are as follows: Strongly Undervalued below -119.88, Undervalued between -119.88 and -58.09, Fairly Valued between 65.49 and -58.09, Overvalued between 65.49 and 127.28, and Strongly Overvalued above 127.28. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-0.19
EV/EBIT
I-Mab. (IMAB) has a current EV/EBIT of -0.19. The 5-year average EV/EBIT is -4.95. The thresholds are as follows: Strongly Undervalued below -29.67, Undervalued between -29.67 and -17.31, Fairly Valued between 7.42 and -17.31, Overvalued between 7.42 and 19.78, and Strongly Overvalued above 19.78. The current Forward EV/EBIT of -0.19 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
I-Mab. (IMAB) has a current PS of 0.00. The 5-year average PS is 14.50. The thresholds are as follows: Strongly Undervalued below -56.20, Undervalued between -56.20 and -20.85, Fairly Valued between 49.84 and -20.85, Overvalued between 49.84 and 85.19, and Strongly Overvalued above 85.19. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
I-Mab. (IMAB) has a current P/OCF of 0.00. The 5-year average P/OCF is 6.95. The thresholds are as follows: Strongly Undervalued below -142.08, Undervalued between -142.08 and -67.57, Fairly Valued between 81.46 and -67.57, Overvalued between 81.46 and 155.98, and Strongly Overvalued above 155.98. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
17.73
P/FCF
I-Mab. (IMAB) has a current P/FCF of 17.73. The 5-year average P/FCF is -22.33. The thresholds are as follows: Strongly Undervalued below -128.41, Undervalued between -128.41 and -75.37, Fairly Valued between 30.71 and -75.37, Overvalued between 30.71 and 83.75, and Strongly Overvalued above 83.75. The current Forward P/FCF of 17.73 falls within the Historic Trend Line -Fairly Valued range.
I-Mab (IMAB) has a current Price-to-Book (P/B) ratio of 0.87. Compared to its 3-year average P/B ratio of 0.55 , the current P/B ratio is approximately 57.87% higher. Relative to its 5-year average P/B ratio of 2.31, the current P/B ratio is about -62.39% higher. I-Mab (IMAB) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -17.88%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -12.41% , the current FCF yield is about -100.00% lower.
0.87
P/B
Median3y
0.55
Median5y
2.31
0.00
FCF Yield
Median3y
-17.88
Median5y
-12.41

Competitors Valuation Multiple

The average P/S ratio for IMAB's competitors is 1.10, providing a benchmark for relative valuation. I-Mab Corp (IMAB) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

Performance Decomposition

1Y
3Y
5Y
Market capitalization of IMAB increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IMAB in the past 1 year is driven by Unknown.

FAQ

arrow icon

Is I-Mab (IMAB) currently overvalued or undervalued?

I-Mab (IMAB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -18.34. The fair price of I-Mab (IMAB) is between NaN to NaN according to relative valuation methord.
arrow icon

What is I-Mab (IMAB) fair value?

arrow icon

How does IMAB's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for I-Mab (IMAB) as of Jul 29 2025?

arrow icon

What is the current FCF Yield for I-Mab (IMAB) as of Jul 29 2025?

arrow icon

What is the current Forward P/E ratio for I-Mab (IMAB) as of Jul 29 2025?

arrow icon

What is the current Forward P/S ratio for I-Mab (IMAB) as of Jul 29 2025?